XML 58 R29.htm IDEA: XBRL DOCUMENT v3.23.4
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies  
Schedule of milestone payments the Company shall pay to Licensor

Milestone Event

    

Amount

Enrollment of first patient in a phase II clinical trial of a therapeutic product or process

$

100,000

Enrollment of first patient in a phase III clinical trial of a therapeutic product or process

$

200,000

First commercial sale of a therapeutic product or process

$

1,000,000

Filing of an application for regulatory approval of a clinical diagnostic product or process

$

100,000

First regulatory approval of a clinical diagnostic product or process

$

150,000